NPI: 1164522165 · SAN FRANCISCO, CA 94108 · 207R00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,984 | $14K |
| 2019 | 6,388 | $15K |
| 2020 | 6,676 | $64K |
| 2021 | 6,797 | $164K |
| 2022 | 5,616 | $106K |
| 2023 | 4,259 | $231K |
| 2024 | 930 | $55K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 20610 | 5,911 | 3,134 | $176K | |
| 99214 | 5,664 | 5,278 | $162K | |
| J7320 | Genvisc 850, inj, 1mg | 661 | 265 | $117K |
| 99215 | Prolong outpt/office vis | 1,588 | 1,538 | $72K |
| J7321 | Hyalgan supartz visco-3 dose | 373 | 176 | $64K |
| 96372 | 3,006 | 1,592 | $27K | |
| J1030 | Methylprednisolone 40 mg inj | 1,788 | 1,614 | $12K |
| 94760 | 4,106 | 3,686 | $6K | |
| 99212 | 617 | 385 | $5K | |
| J7325 | Synvisc or synvisc-one | 2,049 | 1,076 | $4K |
| 95165 | 1,698 | 701 | $2K | |
| 99245 | 15 | 15 | $735.84 | |
| 95115 | 1,708 | 703 | $527.88 | |
| 99211 | 48 | 31 | $75.32 | |
| J7331 | Synojoynt, inj., 1 mg | 19 | 14 | $70.72 |
| 4192F | 994 | 926 | $0.00 | |
| 3476F | 775 | 719 | $0.00 | |
| 3455F | 688 | 640 | $0.00 | |
| G8417 | Calc bmi abv up param f/u | 195 | 173 | $0.00 |
| 99244 | 13 | 13 | $0.00 | |
| 3470F | 13 | 13 | $0.00 | |
| 4195F | 775 | 720 | $0.00 | |
| M1003 | Tb scr 12 mo pri fst bio dz | 953 | 893 | $0.00 |
| 1006F | 642 | 594 | $0.00 | |
| J2001 | Lidocaine injection | 362 | 325 | $0.00 |
| M1007 | >=50% total pt outpt ra enct | 994 | 927 | $0.00 |
| 1170F | 995 | 927 | $0.00 |